Received Jun 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | MZ474 | — |
accidentally administered a pediatric dose of Havrix to an adult patient; accidentally administered a pediatric dose of Havrix to an adult patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of adult use of a child product in a adult patient who received HAV (Havrix pediatric) (batch number MZ474, expiry date 24-APR-2026) for prophylaxis. In MAY-2025, the patient received Havrix pediatric. In MAY-2025, an unknown time after receiving Havrix pediatric, the patient experienced adult use of a child product (Verbatim: accidentally administered a pediatric dose of Havrix to an adult patient) and accidental underdose (Verbatim: accidentally administered a pediatric dose of Havrix to an adult patient). The outcome of the adult use of a child product and accidental underdose were not applicable. Additional Information: GSK Receipt Date: 02-JUN-2025 The pharmacist reported that they accidentally administered a pediatric dose of Havrix to an adult patient, which led to adult use of a child product and accidental underdose